PBAC Recommendation - August 2014 out-of-session meeting

Page last updated: 18 September 2014

An out-of-session meeting was held on 25 August 2014 to discuss the Pharmaceutical Benefits Scheme (PBS) listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome (aHUS). A PBAC outcome statement is available.